The scholarly study Thirty-two patients were enrolled in this single-arm.

Aeterna Zentaris announces outcomes from perifosine Phase 1 trial on multiple myeloma Aeterna Zentaris Inc. This article outlines the safety profile and encouraging medical activity of perifosine when combined with lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma. The scholarly study Thirty-two patients were enrolled in this single-arm, open label Phase 1 trial across 4-dosage cohorts. The primary objectives of the trial were to determine the safety, maximum tolerated dose and response -rate .Enhanced features/efficiency for Aegis’ Hierarchy Verification Utility device used to link and aggregate constant data sources. ‘Discoverant 4.0 was built to help clients expand to multi-site, multi-national manufacturing conditions,’ said Aegis President and CEO Robert Di Scipio. ‘Discoverant 4.0 not only makes data aggregation and analysis easier, it simplifies internal and exterior data sharing also.’ Current Aegis clients can contact their accounts managers for information on upgrades.

5 ways to keep your brain fit The brain is an extremely special part of the human anatomy.